Clinical Trial Update: PATH-03 Paraguay Feasibility Study [NA]

View source ↗

Summary

PATH-03 Paraguay feasibility study is a clinical trial investigating end-stage kidney disease; the trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Kidney Disease

Snippet

Sponsor: Pathfinder Medical | Conditions: Kidney Disease, End-Stage | NA | Status: NOT_YET_RECRUITING